Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
XP ›
XPELCER
Trademark search for:
XPELCER
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-10-21 — Application filed
2020-10-24 — Application filed
2020-12-09 — Application filed
2021-03-22 — Assigned to examiner
2021-03-23 — Priority action written
2021-03-23 — Priority action e-mailed
2021-03-23 — Notification of priority action e-mailed
2021-05-13 — Approved for pub - principal register
2021-05-13 — Teas/email correspondence entered
2021-05-13 — Office action issued
2021-05-13 — Correspondence received in law office
2021-06-02 — Notification of notice of publication e-mailed
2021-06-22 — Published for opposition
2021-06-22 — Official gazette publication confirmation e-mailed
2021-08-17 — Noa e-mailed - sou required from applicant
2022-01-24 — Sou teas extension received
2022-01-24 — Sou extension 1 filed
2022-01-24 — Sou extension 1 granted
2022-01-26 — Notice of approval of extension request e-mailed
2022-08-04 — Sou teas extension received
2022-08-04 — Sou extension 2 filed
2022-08-04 — Sou extension 2 granted
2022-08-06 — Notice of approval of extension request e-mailed
2022-12-13 — Assigned to examiner
2023-01-13 — Sou teas extension received
2023-01-13 — Sou extension 3 filed
2023-01-13 — Sou extension 3 granted
2023-01-17 — Notice of approval of extension request e-mailed
2023-07-17 — Sou teas extension received
2023-07-17 — Sou extension 4 granted
2023-07-17 — Sou extension 4 filed
2023-07-19 — Notice of approval of extension request e-mailed
2024-03-25 — Application abandoned
2024-03-25 — Application abandoned
2024-03-25 — Final status recorded
Owner Information
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Correspondent
Maury M. Tepper, III TEPPER & EYSTER, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
